Real-time enrollment status for this acute myelogenous leukemia clinical trial
Current Status
Suspended
Checked: April 17, 2026 at 5:09 AM UTC
| NCT Number | NCT04278768 |
| Recruiting Status | Suspended |
| Condition | Acute Myelogenous Leukemia |
| Phase | Clinical Trial |
| Target Enrollment | 366 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Curis, Inc. |
| Last Updated on CT.gov | March 19, 2026 (4 weeks ago) |
As of April 17, 2026: Clinical trial NCT04278768 is currently suspended participants. This clinical trial study for acute myelogenous leukemia is not currently accepting new participants at 12 locations across the United States. The study is sponsored by Curis, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT04278768 is currently suspended. The study may resume recruiting in the future.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04278768 was last updated 4 weeks ago (March 19, 2026). HelloStudys verifies this status automatically.